ValiRx plc

VAL.L·LSE·Healthcare
Compare
0.16000.0000 (0.00%)today
As of Nov 5, 10:32 AM GMT · May be delayed up to 15 min · GBX

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.1600
Open0.1600
Day range—
52-week range0.12000.4800
Off day high0.00%
Off 52-week high−66.67%
Volume7.93M
Avg. volume (3M)14.79M
Market cap2.11M
EPS (TTM)0.000000
Forward P/E0.00
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.41
Shares outstanding1.32B
Short interest—
Earnings dateMay 29, 2025 (est.)
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
VAL.L BDRX NFX.L APVO NIKI TOVX
Market cap 2.11M 1.41M 2.87M 2.90M 5.27M 8.72M
P/E (TTM) — 0.0 — 0.0 — 0.3
Forward P/E 0.0 — — -0.1 — -1.0
Price/book 0.4 0.0 1.1 0.3 0.1 0.7
Dividend yield — — — — — —
1-year change −27.66% −98.73% −74.68% −94.72% −87.43% −40.00%
Today 0.00% −4.61% +10.00% +0.74% −3.98% +4.40%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All VAL.L news ›
TradingView·Positive

REG - ValiRx PLC - Update on Ambrose Healthcare shareholding

("ValiRx" or the "Company") London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health, notes the movement in the Company's share price on 20 October 2026 following the…

MarketScreener·Negative

EARNINGS AND TRADING: ValiRx profit slides; Ukrproduct loss narrows

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- ValiRx PLC - London-based life science company - Reports... Biotechnology & Medical Research…

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance